IBDEI0Q1 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11704,1,4,0)
;;=4^K76.7
;;^UTILITY(U,$J,358.3,11704,2)
;;=^56497
;;^UTILITY(U,$J,358.3,11705,0)
;;=N00.0^^46^573^8
;;^UTILITY(U,$J,358.3,11705,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11705,1,3,0)
;;=3^Acute nephritic syndrome w/ minor glomerular abnormality
;;^UTILITY(U,$J,358.3,11705,1,4,0)
;;=4^N00.0
;;^UTILITY(U,$J,358.3,11705,2)
;;=^5015491
;;^UTILITY(U,$J,358.3,11706,0)
;;=N00.1^^46^573^7
;;^UTILITY(U,$J,358.3,11706,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11706,1,3,0)
;;=3^Acute nephritic syndrome w/ focal and segmental glomerular lesions
;;^UTILITY(U,$J,358.3,11706,1,4,0)
;;=4^N00.1
;;^UTILITY(U,$J,358.3,11706,2)
;;=^5015492
;;^UTILITY(U,$J,358.3,11707,0)
;;=N00.2^^46^573^4
;;^UTILITY(U,$J,358.3,11707,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11707,1,3,0)
;;=3^Acute nephritic syndrome w/ diffuse membranous glomrlneph
;;^UTILITY(U,$J,358.3,11707,1,4,0)
;;=4^N00.2
;;^UTILITY(U,$J,358.3,11707,2)
;;=^5015493
;;^UTILITY(U,$J,358.3,11708,0)
;;=N00.3^^46^573^5
;;^UTILITY(U,$J,358.3,11708,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11708,1,3,0)
;;=3^Acute nephritic syndrome w/ diffuse mesangial prolif glomrlneph
;;^UTILITY(U,$J,358.3,11708,1,4,0)
;;=4^N00.3
;;^UTILITY(U,$J,358.3,11708,2)
;;=^5015494
;;^UTILITY(U,$J,358.3,11709,0)
;;=N00.4^^46^573^3
;;^UTILITY(U,$J,358.3,11709,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11709,1,3,0)
;;=3^Acute nephritic syndrome w/ diffuse endocaplry prolif glomrlneph
;;^UTILITY(U,$J,358.3,11709,1,4,0)
;;=4^N00.4
;;^UTILITY(U,$J,358.3,11709,2)
;;=^5015495
;;^UTILITY(U,$J,358.3,11710,0)
;;=N00.5^^46^573^6
;;^UTILITY(U,$J,358.3,11710,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11710,1,3,0)
;;=3^Acute nephritic syndrome w/ diffuse mesangiocap glomrlneph
;;^UTILITY(U,$J,358.3,11710,1,4,0)
;;=4^N00.5
;;^UTILITY(U,$J,358.3,11710,2)
;;=^5015496
;;^UTILITY(U,$J,358.3,11711,0)
;;=N00.6^^46^573^1
;;^UTILITY(U,$J,358.3,11711,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11711,1,3,0)
;;=3^Acute nephritic syndrome w/ dense deposit disease
;;^UTILITY(U,$J,358.3,11711,1,4,0)
;;=4^N00.6
;;^UTILITY(U,$J,358.3,11711,2)
;;=^5015497
;;^UTILITY(U,$J,358.3,11712,0)
;;=N00.7^^46^573^2
;;^UTILITY(U,$J,358.3,11712,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11712,1,3,0)
;;=3^Acute nephritic syndrome w/ diffuse crescentic glomrlneph
;;^UTILITY(U,$J,358.3,11712,1,4,0)
;;=4^N00.7
;;^UTILITY(U,$J,358.3,11712,2)
;;=^5015498
;;^UTILITY(U,$J,358.3,11713,0)
;;=N00.8^^46^573^9
;;^UTILITY(U,$J,358.3,11713,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11713,1,3,0)
;;=3^Acute nephritic syndrome w/ other morphologic changes
;;^UTILITY(U,$J,358.3,11713,1,4,0)
;;=4^N00.8
;;^UTILITY(U,$J,358.3,11713,2)
;;=^5015499
;;^UTILITY(U,$J,358.3,11714,0)
;;=N00.9^^46^573^10
;;^UTILITY(U,$J,358.3,11714,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11714,1,3,0)
;;=3^Acute nephritic syndrome w/ unsp morphologic changes
;;^UTILITY(U,$J,358.3,11714,1,4,0)
;;=4^N00.9
;;^UTILITY(U,$J,358.3,11714,2)
;;=^5015500
;;^UTILITY(U,$J,358.3,11715,0)
;;=N01.0^^46^573^69
;;^UTILITY(U,$J,358.3,11715,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11715,1,3,0)
;;=3^Rapidly progr neph synd w/ minor glomerular abnlt
;;^UTILITY(U,$J,358.3,11715,1,4,0)
;;=4^N01.0
;;^UTILITY(U,$J,358.3,11715,2)
;;=^5015501
;;^UTILITY(U,$J,358.3,11716,0)
;;=N01.1^^46^573^68
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0Q1 3782 printed Apr 09, 2024@21:25:35 Page 2
IBDEI0Q1 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11704,1,4,0)
+2 ;;=4^K76.7
+3 ;;^UTILITY(U,$J,358.3,11704,2)
+4 ;;=^56497
+5 ;;^UTILITY(U,$J,358.3,11705,0)
+6 ;;=N00.0^^46^573^8
+7 ;;^UTILITY(U,$J,358.3,11705,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,11705,1,3,0)
+10 ;;=3^Acute nephritic syndrome w/ minor glomerular abnormality
+11 ;;^UTILITY(U,$J,358.3,11705,1,4,0)
+12 ;;=4^N00.0
+13 ;;^UTILITY(U,$J,358.3,11705,2)
+14 ;;=^5015491
+15 ;;^UTILITY(U,$J,358.3,11706,0)
+16 ;;=N00.1^^46^573^7
+17 ;;^UTILITY(U,$J,358.3,11706,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,11706,1,3,0)
+20 ;;=3^Acute nephritic syndrome w/ focal and segmental glomerular lesions
+21 ;;^UTILITY(U,$J,358.3,11706,1,4,0)
+22 ;;=4^N00.1
+23 ;;^UTILITY(U,$J,358.3,11706,2)
+24 ;;=^5015492
+25 ;;^UTILITY(U,$J,358.3,11707,0)
+26 ;;=N00.2^^46^573^4
+27 ;;^UTILITY(U,$J,358.3,11707,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,11707,1,3,0)
+30 ;;=3^Acute nephritic syndrome w/ diffuse membranous glomrlneph
+31 ;;^UTILITY(U,$J,358.3,11707,1,4,0)
+32 ;;=4^N00.2
+33 ;;^UTILITY(U,$J,358.3,11707,2)
+34 ;;=^5015493
+35 ;;^UTILITY(U,$J,358.3,11708,0)
+36 ;;=N00.3^^46^573^5
+37 ;;^UTILITY(U,$J,358.3,11708,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,11708,1,3,0)
+40 ;;=3^Acute nephritic syndrome w/ diffuse mesangial prolif glomrlneph
+41 ;;^UTILITY(U,$J,358.3,11708,1,4,0)
+42 ;;=4^N00.3
+43 ;;^UTILITY(U,$J,358.3,11708,2)
+44 ;;=^5015494
+45 ;;^UTILITY(U,$J,358.3,11709,0)
+46 ;;=N00.4^^46^573^3
+47 ;;^UTILITY(U,$J,358.3,11709,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,11709,1,3,0)
+50 ;;=3^Acute nephritic syndrome w/ diffuse endocaplry prolif glomrlneph
+51 ;;^UTILITY(U,$J,358.3,11709,1,4,0)
+52 ;;=4^N00.4
+53 ;;^UTILITY(U,$J,358.3,11709,2)
+54 ;;=^5015495
+55 ;;^UTILITY(U,$J,358.3,11710,0)
+56 ;;=N00.5^^46^573^6
+57 ;;^UTILITY(U,$J,358.3,11710,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,11710,1,3,0)
+60 ;;=3^Acute nephritic syndrome w/ diffuse mesangiocap glomrlneph
+61 ;;^UTILITY(U,$J,358.3,11710,1,4,0)
+62 ;;=4^N00.5
+63 ;;^UTILITY(U,$J,358.3,11710,2)
+64 ;;=^5015496
+65 ;;^UTILITY(U,$J,358.3,11711,0)
+66 ;;=N00.6^^46^573^1
+67 ;;^UTILITY(U,$J,358.3,11711,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,11711,1,3,0)
+70 ;;=3^Acute nephritic syndrome w/ dense deposit disease
+71 ;;^UTILITY(U,$J,358.3,11711,1,4,0)
+72 ;;=4^N00.6
+73 ;;^UTILITY(U,$J,358.3,11711,2)
+74 ;;=^5015497
+75 ;;^UTILITY(U,$J,358.3,11712,0)
+76 ;;=N00.7^^46^573^2
+77 ;;^UTILITY(U,$J,358.3,11712,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,11712,1,3,0)
+80 ;;=3^Acute nephritic syndrome w/ diffuse crescentic glomrlneph
+81 ;;^UTILITY(U,$J,358.3,11712,1,4,0)
+82 ;;=4^N00.7
+83 ;;^UTILITY(U,$J,358.3,11712,2)
+84 ;;=^5015498
+85 ;;^UTILITY(U,$J,358.3,11713,0)
+86 ;;=N00.8^^46^573^9
+87 ;;^UTILITY(U,$J,358.3,11713,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,11713,1,3,0)
+90 ;;=3^Acute nephritic syndrome w/ other morphologic changes
+91 ;;^UTILITY(U,$J,358.3,11713,1,4,0)
+92 ;;=4^N00.8
+93 ;;^UTILITY(U,$J,358.3,11713,2)
+94 ;;=^5015499
+95 ;;^UTILITY(U,$J,358.3,11714,0)
+96 ;;=N00.9^^46^573^10
+97 ;;^UTILITY(U,$J,358.3,11714,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,11714,1,3,0)
+100 ;;=3^Acute nephritic syndrome w/ unsp morphologic changes
+101 ;;^UTILITY(U,$J,358.3,11714,1,4,0)
+102 ;;=4^N00.9
+103 ;;^UTILITY(U,$J,358.3,11714,2)
+104 ;;=^5015500
+105 ;;^UTILITY(U,$J,358.3,11715,0)
+106 ;;=N01.0^^46^573^69
+107 ;;^UTILITY(U,$J,358.3,11715,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,11715,1,3,0)
+110 ;;=3^Rapidly progr neph synd w/ minor glomerular abnlt
+111 ;;^UTILITY(U,$J,358.3,11715,1,4,0)
+112 ;;=4^N01.0
+113 ;;^UTILITY(U,$J,358.3,11715,2)
+114 ;;=^5015501
+115 ;;^UTILITY(U,$J,358.3,11716,0)
+116 ;;=N01.1^^46^573^68
